HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Contoured Diaphragm Offers Nonhormonal Contraception

By HospiMedica International staff writers
Posted on 14 Jul 2015
Print article
Image: The Caya diaphragm (Photo courtesy of Kessel MEDintim).
Image: The Caya diaphragm (Photo courtesy of Kessel MEDintim).
A single-size, reusable diaphragm offers an improved barrier method for birth control, expanding options for women who do not want hormonal treatments.

The Caya contoured diaphragm is made of silicone—which is more durable than diaphragms made from latex—providing a shelf life of five years and a use life of up to two years. User-centered design features include a rim that contains a proprietary nylon spring that compresses during insertion and removal; grip dimples on the rim of the device offer a cue where to squeeze it for insertion, and a removal dome. As one size fits most women, there is no need for a fitting exam to determine correct diaphragm size.

The Caya diaphragm is inserted into the vagina like a tampon just before sexual intercourse. It fully covers the cervical os and is placed between the posterior vaginal vault and the space behind the pubic bone. During and after intercourse, the Caya prevents sperms from entering the uterus, but it must remain in the vagina for at least six hours. The Caya diaphragm is a product of Kessel MEDintim (Mörfelden-Walldorf, Germany), and has been approved by the US Food and Drug Administration (FDA).

“In talking with family planning providers about this single-size diaphragm over the past few months, their eyes 'light up' when they hear that a new diaphragm is coming to market and no fitting exam is required,” said Bob Patane, founder of HPSRx (Salem, VA, USA), designated marketer of the Caya in the USA. “Reducing barriers at the provider level could help bring this new method to a whole new generation of women who have not known that diaphragms are even an option.”

The Caya diaphragm was designed through a collaboration between PATH (Seattle, WA, USA), a global health nonprofit organization; CONRAD (Norfolk, VA, USA), a reproductive health product development organization operated through the Eastern Virginia Medical School (Norfolk, VA, USA); and the United States Agency for International Development (USAID, Washington DC, USA). During product development and clinical studies, it was called the SILCS diaphragm.

“Clinical studies confirm the single-size design fits most women who could wear a traditional diaphragm. In the recently published contraceptive effectiveness study, 76% of women were able to insert and correctly position the diaphragm simply using instructions,” said Gustavo Doncel, MD, PhD, scientific and executive director of CONRAD. “With coaching, 94% of women were able to insert, correctly position, and remove the diaphragm. This should make it easier to provide and use consistently.”

“This woman-initiated, nonhormonal contraceptive barrier method has great potential to improve women’s reproductive health options by addressing several of the reasons for unmet contraceptive need,” said Judy Manning, team lead for contraceptive research and development at USAID. “The device may fill another needed role by serving as a delivery method for gels that help protect against HIV and other sexually transmitted infections. It could be our first true multipurpose prevention product.”

Related Links:

Kessel MEDintim
HPSRx 
PATH


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The Nami S miniaturized ultrasonic scalpel enables faster and safer RAS (Photo courtesy of Nami Surgical)

Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery

Robot-assisted surgery (RAS) has gained significant popularity in recent years and is now extensively used across various surgical fields such as urology, gynecology, and cardiology. These surgeries, performed... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more